FC
SGMO

FIC Capital’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

FIC Capital’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$13.6M Sell
909,437
-50,901
-5% -$563K 5.2% 3
2017
Q2 		$8.45M Buy
960,338
+19,429
+2% +$125K 3.48% 4
2017
Q1 		$4.89M Buy
940,909
+65,625
+7% +$263K 2.17% 9
2016
Q4 		$2.67M Buy
875,284
+15,445
+2% +$56.2K 1.34% 28
2016
Q3 		$3.98M Sell
859,839
-2,650
-0.3% -$13.5K 1.79% 16
2016
Q2 		$4.99M Sell
862,489
-55
-0% -$351 2.36% 7
2016
Q1 		$5.22M Sell
862,544
-7,670
-0.9% -$46.1K 2.53% 8
2015
Q4 		$7.95M Sell
870,214
-10,815
-1% -$83.3K 3.52% 4
2015
Q3 		$4.97M Buy
881,029
+93,500
+12% +$771K 2.33% 14
2015
Q2 		$8.73M Buy
787,529
+4,050
+0.5% +$52.2K 3.47% 3
2015
Q1 		$12.3M Sell
783,479
-1,050
-0.1% -$16.2K 4.67% 2
2014
Q4 		$11.9M Buy
784,529
+25,375
+3% +$308K 4.62% 2
2014
Q3 		$8.19M Buy
759,154
+23,105
+3% +$302K 3.27% 3
2014
Q2 		$11.2M Sell
736,049
-260
-0% -$3.74K 4.38% 1
2014
Q1 		$13.3M Buy
736,309
+26,495
+4% +$511K 5.44% 1
2013
Q4 		$9.86M Buy
709,814
+34,275
+5% +$395K 4.42% 1
2013
Q3 		$7.09M Sell
675,539
-557
-0.1% -$5.53K 3.6% 3
2013
Q2 		$5.28M Buy
+676,096
New +$5.9M 3.38% 2

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FIC Capital's SGMO Position: Q3 2017 in Review

FIC Capital reduced its SANGAMO THERAPEUTICS INC (SGMO) stake by 5.3% in Q3 2017, selling an estimated $563K and leaving 909,437 shares worth $13.6M. The position accounts for 5.2% of the portfolio, ranked #3.

FIC Capital first reported a position in SGMO in Q2 2013 and has held it in 18 quarters since. 148 funds tracked by Wall St. Rank hold SGMO as of Q3 2017.

  • FIC Capital held 909,437 shares of SANGAMO THERAPEUTICS INC worth $13.6M as of Q3 2017.
  • FIC Capital sold 50,901 SANGAMO THERAPEUTICS INC shares in Q3 2017, an estimated $563K.
  • SANGAMO THERAPEUTICS INC made up 5.2% of FIC Capital's portfolio in Q3 2017, its #3 holding.
  • FIC Capital first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 18 quarters since.
  • 148 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2017.

Based on FIC Capital's 13F filing for Q3 2017, filed 14 Nov 2017.